Despite the widespread use of corticosteroids in patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, the dose–response relationship between corticosteroid treatment, plasma glucose (PG) levels, and subsequent insulin requirements remains less studied. This evidence concerns the gene INS and COVID-19.